Fuad H AlNadwi

Title: Fuad H AlNadwi: Innovator in Metabolic Disorder Treatment

Introduction

Fuad H AlNadwi is a prominent inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of pharmaceutical technology, particularly in the treatment of metabolic disorders. His innovative approach combines advanced 3D printing techniques with self-nanoemulsifying drug delivery systems.

Latest Patents

AlNadwi holds a patent for "Methods for treating metabolic disorder." This patent describes a self-nanoemulsifying 3D printer ink composition and a method for using this composition to manufacture a 3D-printed tablet. The tablet features compartmentalized active pharmaceutical ingredients, specifically glimepiride and/or rosuvastatin, within a curcuma oil-based self-nanoemulsifying drug delivery system (SNEDDS). The invention provides a method for treating metabolic disorders by administering a therapeutically effective amount of the 3D-printed tablet to individuals in need.

Career Highlights

Fuad H AlNadwi is affiliated with King Abdulaziz University, where he contributes to research and development in pharmaceutical sciences. His work focuses on innovative drug delivery systems that enhance the efficacy of treatments for metabolic disorders.

Collaborations

AlNadwi collaborates with notable colleagues, including Khalid Mohamed El-Say and Tarek Abdelnapy Ahmed. Their combined expertise fosters a dynamic research environment that promotes advancements in pharmaceutical technology.

Conclusion

Fuad H AlNadwi's contributions to the field of metabolic disorder treatment through innovative 3D printing techniques and drug delivery systems highlight his role as a leading inventor. His work continues to pave the way for new therapeutic options in the pharmaceutical industry.